Legacy Capital Group California’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.46M Buy
20,260
+5,510
+37% +$424K 0.55% 32
2025
Q4
$1.17M Sell
14,750
-59
-0.4% -$4.65K 0.28% 87
2025
Q3
$1.12M Buy
14,809
+92
+0.6% +$6.3K 0.28% 89
2025
Q2
$1.02M Sell
14,717
-384
-3% -$25.2K 0.28% 93
2025
Q1
$1.02M Sell
15,101
-133
-0.9% -$7.96K 0.36% 54
2024
Q4
$684K Sell
15,234
-88
-0.6% -$4.94K 0.21% 134
2024
Q3
$963K Sell
15,322
-386
-2% -$22.5K 0.32% 76
2024
Q2
$928K Buy
15,708
+5,165
+49% +$323K 0.33% 80
2024
Q1
$841K Sell
10,543
-222
-2% -$17K 0.31% 100
2023
Q4
$850K Buy
10,765
+72
+0.7% +$5.12K 0.33% 83
2023
Q3
$747K Sell
10,693
-9,538
-47% -$676K 0.32% 89
2023
Q2
$1.4M Buy
20,231
+2,960
+17% +$211K 0.58% 28
2023
Q1
$1.28M Buy
+17,271
New +$1.45M 0.63% 42

Other funds holding CVS

Legacy Capital Group California's CVS Position: Q1 2026 in Review

Legacy Capital Group California increased its CVS Health (CVS) stake by 37% in Q1 2026, buying an estimated $424K and bringing the position to 20,260 shares worth $1.46M. The position accounts for 0.55% of the portfolio, ranked #32.

Legacy Capital Group California first reported a position in CVS in Q1 2023 and has held it in 13 quarters since. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Legacy Capital Group California held 20,260 shares of CVS Health worth $1.46M as of Q1 2026.
  • Legacy Capital Group California bought 5,510 CVS Health shares in Q1 2026, an estimated $424K.
  • CVS Health made up 0.55% of Legacy Capital Group California's portfolio in Q1 2026, its #32 holding.
  • Legacy Capital Group California first reported a position in CVS Health in Q1 2023 and has held it in 13 quarters since.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.